Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by saveyourselfnowon Aug 19, 2018 3:17pm
82 Views
Post# 28484033

RE:RE:Question for you

RE:RE:Question for you
ProfCornelius wrote: How about tripling? Which LP will accomplish that in 2019 from these current levels? PROF
FrenchFrogDom wrote: Who has the better chance to double the value of the stock price now ?
CGC with a value on 20-25 billions after the deal, which means they have to go to an 40-50 billions evaluation (just illogical) or APH with a value of 2.5 billions, which need to go to 5 billions still having many catalysts in front of them ?

Dom




See?  That's the problem with you PROF.  You take the current share price of an entity, and if you own a postition in that entity, you make predictions of 300% gains JUST BECAUSE your are comparing 2 MUTUALLY EXCLUSIVE postitions based on share price projections.

Of course, the dummy says $10 to $30 seems easier to achieve than $50 to $150.

Here's the dilemma and the issue - Why oh Why is the competition $50 when APH is at $11?

Because the competition is the better buy!

It's CALLED A MARKET for a reason, you con artist - the market has spoken and YOU SAY THE MARKET IS WRONG???

The alternative is - "i will invest in the PTX - "The Proffesor Exchange" because the TSX and all it's tentacles (an entire industry of analysts and their scientifcially assigned algorythms, ARE WRONG".

you can have an opinion gewf but you need to sign your opionions IMHO!!!

D R O P   D  E A D  you  l o s e r   and failed c o n   a r t i s t  !


IMHO

Bullboard Posts